Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Apr 11;14(8):2623.
doi: 10.3390/jcm14082623.

Evaluation of Long-Term Response to Biological Therapy in Severe Asthma and Considerations for Treatment Adjustment

Jordan Giordani  1 , Alessandro Pini  2 , Laura Pini  1   3
Affiliations
Editorial

Evaluation of Long-Term Response to Biological Therapy in Severe Asthma and Considerations for Treatment Adjustment

Jordan Giordani et al. J Clin Med. .

Abstract

Assessing long-term responses to biological therapies for severe asthma is critical for optimizing patient management and improving clinical outcomes [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

References

    1. Brusselle G.G., Koppelman G.H. Biologic Therapies for Severe Asthma. N. Engl. J. Med. 2022;386:157–171. doi: 10.1056/NEJMra2032506. - DOI - PubMed
    1. Domingo C., Mirapeix R.M., González-Barcala F.J., Forné C., García F. Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel Study. Drugs. 2023;83:1111–1123. doi: 10.1007/s40265-023-01905-5. - DOI - PubMed
    1. Varricchi G., Poto R., Lommatzsch M., Brusselle G., Braido F., Virchow J.C., Canonica G.W. Biologics and airway remodeling in asthma: Early, late, and potential preventive effects. Allergy. 2025;80:408–422. doi: 10.1111/all.16382. - DOI - PMC - PubMed
    1. Visca D., Ardesi F., Zappa M., Grossi S., Pignatti P., Vanetti M., Pini L., Sotgiu G., Centis R., Migliori G.B., et al. The effect of benralizumab on inflammation in severe asthma: A real-life analysis. Ther. Adv. Respir. Dis. 2024;18 doi: 10.1177/17534666241304685. - DOI - PMC - PubMed
    1. Tajiri T., Suzuki M., Nishiyama H., Ozawa Y., Kurokawa R., Takeda N., Ito K., Fukumitsu K., Kanemitsu Y., Mori Y., et al. Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: A prospective, observational study. Allergol Int. 2024;73:406–415. doi: 10.1016/j.alit.2024.02.002. - DOI - PubMed

Publication types

LinkOut - more resources